483
Jerome Stevens Pharmaceuticals, Inc.Jerome Stevens Pharmaceuticals, Inc. – FDA 483, Apr 11, 2019
Record Details
An FDA inspection of Jerome Stevens Pharmaceuticals, Inc. in Bohemia, NY, revealed significant deficiencies in their postmarketing adverse drug experience reporting system. The firm lacked adequate written procedures for surveillance, evaluation, and reporting of adverse drug events, and failed to submit required periodic reports and timely 15-day alert reports. These issues indicate a systemic failure to comply with adverse drug event reporting regulations.
View Company Profile
ID · 028b311f-2783-4c36-8863-13423179382b
Other documents for Jerome Stevens Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.